Abstract

Innate cellular antiviral defenses are likely to influence the outcome of infections by many human viruses, including hepatitis B and C viruses, agents that frequently establish persistent infection leading to chronic hepatitis, cirrhosis, and liver cancer. However, little is known of the pathways by which hepatocytes, the cell type within which these hepatitis agents replicate, sense infection, and initiate protective responses. We show that cultured hepatoma cells, including Huh7 cells, do not activate the interferon (IFN)-beta promoter in response to extracellular poly(I-C). In contrast, the addition of poly(I-C) to culture media activates the IFN-beta promoter and results in robust expression of IFN-stimulated genes (ISG) in PH5CH8 cells, which are derived from non-neoplastic hepatocytes transformed with large T antigen. Small interfering RNA knockdown of TLR3 or its adaptor, Toll-interleukin-1 receptor domain-containing adaptor inducing IFN-beta (TRIF), blocked extracellular poly(I-C) signaling in PH5CH8 cells, whereas poly(I-C) responsiveness could be conferred on Huh7 hepatoma cells by ectopic expression of Toll-like receptor 3 (TLR3). In contrast to poly(I-C), both cell types signal the presence of Sendai virus infection through a TLR3-independent intracellular pathway requiring expression of retinoic acid-inducible gene I (RIG-I), a putative cellular RNA helicase. Silencing of RIG-I expression impaired only the response to Sendai virus and not extracellular poly(I-C). We conclude that hepatocytes contain two distinct antiviral signaling pathways leading to expression of type I IFNs, one dependent upon TLR3 and the other dependent on RIG-I, with little cross-talk between these pathways.

Highlights

  • Innate cellular antiviral defenses are likely to influence the outcome of infections by many human viruses, including hepatitis B and C viruses, agents that frequently establish persistent infection leading to chronic hepatitis, cirrhosis, and liver cancer

  • The molecular basis for induction of IFN-␤ expression has been extensively studied and shown to be induced by dsRNA or other products of virus infection through coordinate activation of transcription factors IFN regulatory factor 3 (IRF-3), NF-␬B, and ATF-2/c-Jun [2]. Most of these studies were conducted in human embryonic kidney 293 or epithelial cells, and relatively little is known about these events in hepatocytes, which constitute ϳ80% of the liver cell population [32], and are the primary cells within which both hepatitis B virus (HBV) and hepatitis C virus (HCV) replicate

  • Because primary differentiated hepatocytes are difficult to maintain in culture, we studied 3 different continuous cell lines derived from human hepatocellular carcinomas: Huh7 cells, which appear to be permissive for HCV RNA replication [33, 34]; HepG2 cells and Hep3B cells, the latter of which contains integrated HBV DNA and express the HBV envelope protein, HBsAg [35]

Read more

Summary

Introduction

Innate cellular antiviral defenses are likely to influence the outcome of infections by many human viruses, including hepatitis B and C viruses, agents that frequently establish persistent infection leading to chronic hepatitis, cirrhosis, and liver cancer. Yoneyama and colleagues [19] have demonstrated recently that IFN-␤ production is induced in response to Newcastle disease virus infection through a pathway that is independent of TLR3 but requires the retinoic acid-inducible gene I (RIG-I, or DDX58), a cellular RNA helicase with homology to caspase-recruitment domain (CARD) proteins. The ability of these pathways to induce the expression of type I IFNs and subsequently a wide array of IFN-stimulated genes (ISGs) is likely to influence the outcome of infection by many human viruses. These responses may play critical roles in shaping subsequent adaptive T cell responses that are required for the ultimate elimination of viruses [21, 22]

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call